Benjamin G. Keselowsky

Benjamin G. Keselowsky is a Professor in the J. Crayton Pruitt Family Department of Biomedical Engineering at the University of Florida's Herbert Wertheim College of Engineering. His research focuses on engineering biomaterial-immune cell interactions and controlled release systems for immunotherapies, with applications in implanted devices, vaccines, and tissue engineering. He holds a B.S. in Chemical Engineering (University of South Florida, 1998) and a Ph.D. in Bioengineering (Georgia Institute of Technology, 2004).

Key honors include AIMBE Fellowship (2018), UF Preeminence Term Professorship (2017-2020), and UF Research Foundation Professorship (2015-2018). His work bridges biomaterials science and immunology, emphasizing translational strategies for immune modulation. Recent efforts include developing bioresorbable alloys, enzyme-delivery systems, and antigen-specific microparticle therapies.

• Education: B.S., Chemical Engineering, University of South Florida (1998); Ph.D., Bioengineering, Georgia Tech (2004)
• Research Themes:
  • Biomaterial-Immune System Interactions
  • Controlled Release of Immune Modulators
  • Tissue Engineering and Regenerative Medicine
• Awards:
  • AIMBE Fellow (2018)
  • UF Preeminence Term Professor (2017-2020)
  • UF Research Foundation Professor (2015-2018)

His lab's innovations include microparticle systems for treating autoimmune diseases and enzymatic gels for localized therapy. Collaborations span biomaterials design, immunotherapy development, and clinical translation.